Pacira BioSciences, Inc. (PCRX)

Operating profit margin

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating income	US$ in thousands	-73,371	87,675	60,024	131,065	46,350
Revenue	US$ in thousands	700,966	674,978	666,823	541,533	420,830
Operating profit margin		-10.47%	12.99%	9.00%	24.20%	11.01%

December 31, 2024 calculation

Operating profit margin = Operating income ÷ Revenue
= $-73,371K ÷ $700,966K
= -10.47%

Based on the provided data, Pacira BioSciences, Inc.'s operating profit margin has shown some fluctuations over the years.

- In 2020, the operating profit margin was 11.01%, indicating that the company generated $0.11 in operating profit for every $1 in sales.
- By the end of 2021, the operating profit margin improved significantly to 24.20%, suggesting better cost management or increased revenues.
- However, in 2022, the operating profit margin dropped to 9.00%, which might suggest challenges in controlling operating expenses or a decline in sales.
- The operating profit margin then rebounded in 2023 to 12.99%, indicating a partial recovery.
- Surprisingly, by the end of 2024, the operating profit margin turned negative at -10.47%, which could signify that the company's operating expenses exceeded its operating income.

Overall, Pacira BioSciences, Inc.'s operating profit margin has been volatile, showing both improvements and setbacks, which could indicate fluctuations in the company's operational efficiency and profitability over the years.